Some people who have received a dose of the messenger RNA vaccine have a tendency to develop heart infections, including myocarditis or pericarditis. While these cases are relatively rare in the areas where they were reported, the risks of having them are lower compared to the benefits of the mentioned vaccines. Canadian health officials recently issued recommendations following these cases.
“We are closely monitoring the development of the situation”
For people who had problems with pericarditis or myocarditis after the first dose of vaccine, the National Advisory Committee on Immunization (NACI) recommended “waiting until more information is available before receiving their vaccine. Second dose”. In a statement, Dr. Shelley Deeks, Chair of the Committee: “We are closely monitoring the development of rare cases of myocarditis or pericarditis that occur in young people after the administration of an mRNA vaccine. NACI is encouraged that the clinical picture appears mild and clears quickly. In addition, the NACI recommended that people wishing to receive an mRNA vaccine be informed about the “very rare risk of post-immunization myocarditis or pericarditis”.
Note that the Canadian authorities had reassured the myocarditis and pericarditis cases. Theresa Tam, Chief Public Health Officer, had emphasized that the benefits of mRNA vaccines outweigh the risks of myocarditis or pericarditis. “I’d like to let Canadians know that the benefits of COVID-19 mRNA vaccines continue to outweigh their potential risks. It is important that everyone gets their second dose of vaccine to get the best protection possible, ”she said.